New issue of 'Global Fund News Flash' available

NewsGuard 100/100 Score
Jul 4 2012

The Global Fund to Fight AIDS, Tuberculosis and Malaria on Tuesday released Issue 5 of its newsletter, the "Global Fund News Flash." The issue reports that strategic planners at the Global Fund "are designing a new funding model"; notes the "Japan Center for International Exchange announced last week that its new president, Ken Shibusawa, would also become director of the Friends of the Global Fund, Japan (FGFJ)"; profiles Ade Fakoya, senior adviser on HIV and AIDS at the Global Fund; and highlights a speech by U.S. Global AIDS Coordinator Ambassador Eric Goosby delivered at the Brookings Institution in Washington last week in which he "praised the reforms being undertaken at the Global Fund" (7/3).

http://www.kaiserhealthnews.orgThis article was reprinted from kaiserhealthnews.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Posted in: Disease/Infection News | Healthcare News

Tags: , , , , , , , ,

Comments (0)

Suggested Reading

Study reveals lasting lung damage in tuberculosis survivors
Ministers of Health commit to accelerated action against malaria in Africa
WHO releases an investment case for TB screening and preventive treatment
Oxford University and Brazil partner to advance malaria vaccine development
Innovative malaria prodrug targets liver, enhances efficacy while reducing toxicity, preclinical studies show
Pioneering study launched to examine how the immune system responds to repeated malaria infections
The path to a better tuberculosis vaccine runs through Montana
New study finds interferon-γ release assays more effective than skin tests in predicting tuberculosis

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
New malaria vaccine strain shows promise in preclinical trials